SEARCH

SEARCH BY CITATION

References

  • 1
    Bean RH. The treatment of ulcerative colitis with anti-metabolites. Br Med J 1966; 1: 1081 4.
  • 2
    Rosenberg JL, Wall AJ, Levin B, Binder HJ, Kirsner JB. A controlled trial of azathioprine in the management of ulcerative colitis. Gastroenterology 1975; 69: 96 9.
  • 3
    Kirk AP & Lennard-Jones JL. Controlled trial of azathioprine in the management of chronic ulcerative colitis. Br Med J 1982; 284: 1291 2.
  • 4
    Caprilli R, Carratu R, Babbini M. A double-blind comparison of the effectiveness of azathioprine and sulphasalazine in idiopathic proctocolitis. Am J Dig Dis 1975; 20: 115 20.
  • 5
    Jewell DP & Truelove SC. Azathioprine in ulcerative colitis: final report on a controlled clinical trial. Br Med J 1974; 4: 627 30.
  • 6
    Hawthorne AB, Logan RFA, Hawkey CJ, et al. Randomized controlled trial of azathioprine withdrawal in ulcerative colitis. Br Med J 1992; 305: 20 2.
  • 7
    Gupta S, Keshavarzain A, Hodgson HJF. Cyclosporin in ulcerative colitis. Lancet 1984; 2: 1277 8.
  • 8
    Baker K & Jewell DP. Cyclosporin for the treatment of severe inflammatory bowel disease. Aliment Pharmacol Ther 1989; 3: 143 9.
  • 9
    Sandborn WJ. A critical review of cyclosporin therapy in inflammatory bowel disease. Inflamm Bowel Dis 1995; 1: 48 63.
  • 10
    Carbonnel F, Boruchowicz A, Duclos B, et al.Intravenous cyclosporin in attacks of ulcerative colitis. Short term and long term responses. Dig Dis Sci 1996; 41: 2471 6.
  • 11
    Stack WA, Long RG, Hawkey CJ. Short and long term outcome with cyclosporin for acute ulcerative colitis. Aliment Pharmacol Ther 1998; 12: 973 8.
  • 12
    Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporin in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330: 1841 51.
  • 13
    Poulson RJ, Mee AS, Misiewicz J. Medical management of ulcerative colitis. In: Misiewicz JJ, Pounder RE, Venables CW, eds. Diseases of the Gut and Pancreas, 2nd edn. Oxford: Blackwell Scientific Publications, 1994: 699–708.
  • 14
    Barkin JS & Green JA. Inflammatory bowel disease; medical management. In: Haubrick WS, Schaffner F, Berk JE, eds. Bockus Gastroenterology, 5th edn. Philadelphia: W.B. Saunders, 1995: 1374–81.
  • 15
    Meuwissen SGM, Ewe K, Gassull MA, et al.International Organisation of Inflammatory Bowel Disease. Questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin-A and methotrexate in the treatment of I.B.D. Gut 1996; 39(Suppl. 3): A242A242(Abstract).
  • 16
    Kozarek R, Bedard C, Patterson D, et al.Cyclosporin use in the precolectomy chronic ulcerative colitis patient: a community experience and its relationship to controlled clinical trials. Am J Gastroenterol 1995; 90: 2093 6.
  • 17
    Fernandez-Banares F, Bertran X, Estive-Comas M, et al. Azathioprine is useful in maintaining long term remission induced by intravenous cyclosporin in steroid-refractory ulcerative colitis. Am J Gastroenterol 1996; 91: 2498 9.
  • 18
    Kornbluth A, Present DH, Lichtiger S, Hanauer S. Cyclosporin for severe ulcerative colitis. A user’s guide. Am J Gastroenterol 1997; 92: 1424 8.
  • 19
    Smith MB & Hanauer SB. Pneumocystis carinii pneumonia during cyclosporin treatment for ulcerative colitis. N Engl J Med 1992; 327: 497 8.
  • 20
    Quan VA, Saunders BP, Hicks BH, Sladen GE. Lesson of the week. Cyclosporin treatment for ulcerative colitis complicated by a fatal Pneumocystis carinii pneumonia. Br Med J 1997; 314: 363 4.
  • 21
    Sandborn WJ & Tremaine WJ. Cyclosporin treatment of inflammatory bowel disease. Mayo Clin Proc 1992; 67: 981 90.